American Leprosy Missions is committed to bringing an END to leprosy by developing a leprosy vaccine that will stop this terrible disease before it even starts.
So in 2002, American Leprosy Missions began a partnership with the Infectious Disease Research Institute (IDRI) in Seattle, Washington to develop a vaccine for leprosy.
This investment of 15 years and $5.1 million has resulted in a vaccine that is now ready for Phase I clinical safety trials in healthy human volunteers.
This is an exciting opportunity to partner with us to make a lasting difference in the world by opening the door to finally stopping this devastating disease.
Why is a leprosy vaccine needed?
- This ancient disease is still disabling and isolating people.
- Every two minutes someone is diagnosed with leprosy.
- More than four million people in the world suffer from leprosy-related disabilities.
- An effective vaccine will limit infection, prevent disease and reduce transmission.
- A vaccine is the only way to end this terrible disease.
What is the current status of the leprosy vaccine?
Thanks to the generous support of people like you, a leprosy vaccine has been developed and manufactured in a large enough quantity for further testing. Toxicology studies are complete, and now the vaccine is ready for the Phase I clinical trial (safety study in healthy human volunteers).
We are ready to sign an agreement with the Phase I clinical trial site and finally start this exciting part of the leprosy vaccine process.
- This is the first leprosy-specific vaccine to go through Phase I clinical trials.
- We believe this vaccine will be an exciting new way to stop the transmission of leprosy and the only way to protect people from the disease long term.
- What’s more, the vaccine may protect against nerve damage, the most serious complication of leprosy.
- The vaccine is manufactured and just waiting to be tested.
- A Phase I clinical trial site has been selected and has scheduled the testing.
- This is an historic opportunity to help end an ancient disease.
- With your help, families will never have to hear the devastating news that they have leprosy, nor suffer its debilitating effects.
- You can leave a lasting legacy for millions of people around the world.
Thanks to your generous support, we have raised $785,708 of the $1,206,501 needed for the leprosy vaccine Phase I clinical trial. This is enough for us to move forward!
And the next exciting milestone has already been reached: The vaccine has received approval from the U.S. Food and Drug Administration.
This vaccine may be the most exciting breakthrough in leprosy treatment since the cure, multi-drug therapy, was launched in the 1980s.
Together we have reached this historic moment. Thank you!
If you’d like to contribute to the leprosy vaccine, we still need $420,793 in order to finish the Phase I clinical trial. Donate now.
August 2017: Food and Drug Administration approval — Successfully completed!
August 2017: Sign agreement with Phase I clinical trial site
September 2017: Start Phase I clinical trial
Summer 2018: Possible start of Phase II clinical trial in an endemic country
Summer 2019: Complete Phase I clinical trial
Join us – Together we can help end leprosy
By God’s grace and with your partnership, a vaccine will be able to spare children like Marc Jun the devastation and heartbreak of leprosy. Donate now to stop the suffering.
Leprosy vaccine in the news
Trial Set for World’s First Leprosy Vaccine, published in the Guardian on June 6, 2014
Can Leprosy Be Eradicated? published in Slate on February 20, 2013 about the leprosy vaccine and rapid diagnostic test